BRCA research information

BRCA research information

Effect of Fenretinide on Ovarian Carcinoma Occurrence
Effect of Radiotherapy After Breast-Conserving Treatment in Women With Breast Cancer and Germline BRCA1/2 Mutations
BRCA1 and BRCA2 information
Reproductive Factors and Ovarian Cancer Risk in Jewish BRCA1 And BRCA2 Mutation Carriers (United States)
Genetics of cancer
Ovarian Cancer Risk in Ashkenazi Jewish Carriers of BRCA1 and BRCA2 Mutations
A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment
Frequency of BRCA1 and BRCA2 Mutations in Unselected Ashkenazi Jewish Patients With Colorectal Cancer
The Risk of Cancer Associated with Specific Mutations of BRCA1 and BRCA2 among Ashkenazi Jews
On the Use of Familial Aggregation in Population-Based Case Probands for Calculating Penetrance
Smoking and the risk of breast cancer among carriers of BRCA mutations
American Cancer Society Guidelines for Breast Cancer Screening: Update 2003
Efficacy of Bilateral Prophylactic Mastectomy in Women with a Family History of Breast Cancer
Reoperations after prophylactic mastectomy with or without implant reconstruction
TGFBR1*6A and Cancer Risk: A Meta-Analysis of Seven Case-Control Studies
Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2
Effect of BRCA Mutations on the Length of Survival in Epithelial Ovarian Tumors
Two The presence of hereditary BRCA1 gene mutations in women with familial breast or ovarian cancer
The genetic attributable risk of breast and ovarian cancer
Risk of Endometrial Carcinoma Associated with BRCA Mutation
Life Insurance and Breast Cancer risk Assessment: Adverse Selection, Genetic Testing Decisions, and Discrimination
Genetic testing for a BRCA1 mutation: Prophylactic Surgery and Screening behavior in women 2 years post testing
Life Expectancy Gains From Cancer Prevention Strategies for Women With Breast Cancer and BRCA1 or BRCA2 Mutations
MRI of Occult Breast Carcinoma in a High-Risk Population
Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
Effect of Radiotherapy After Breast-Conserving Treatment in Women With Breast Cancer and Germline BRCA1/2 Mutations
Variation in Cancer Risks, by Mutation Position, in BRCA2 Mutation Carriers
Two Percent of Men with Early-Onset Prostate Cancer Harbor Germline Mutations in the BRCA2 Gene
A Genetic Epidemiological Study of Carcinoma of the Fallopian Tube
The Lifetime Risks of Breast Cancer in Ashkenazi Jewish Carriers of BRCA1 and BRCA2 Mutations
Oral Contraceptives and the Risk of Hereditary Ovarian Cancer
Using Sonography to Screen Women with Mammographically Dense Breasts
Oral Contraceptives and the Risk of Breast Cancer in BRCA1 and BRCA2 Mutation Carriers
Tamoxifen and Risk of Contralateral Breast Cancer in BRCA1 And BRCA2 Mutation Carriers: A Case-Control Study
Cancer Risks in BRCA2 Mutation Carriers
BRCA2 Gene Mutations in Families With Aggregations of Breast and Stomach Cancers
BRCA1 Functions as a Differential Modulator of Chemotherapy-Induced Apoptosis
The Effectiveness of the Gail Model in Estimating Risk for Development of Breast Cancer in women under 40 years of age
Prevalence of BRCA1 and BRCA2 germline mutations in young breast cancer patients: A population-based study
Tamoxifen and Breast Cancer Incidence Among Women With Inherited Mutations in BRCA1 and BRCA2
Effects of Tamoxifen on Benign Breast Disease in Women at High Risk for Breast Cancer
Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers
Effectiveness of Modena Surveillance Program for Women at Risk For Breast Cancer
A CHEK2 Genetic Variant Contributing to a Substantial Fraction of Familial Breast Cancer
Breast-feeding and the Risk of Breast Cancer in BRCA1 and BRCA2 Mutation Carriers
Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer Families
Cancer Incidence in BRCA1 Mutation Carriers
A new scoring system for the chances of identifying a BRCA1/2 mutation
BRCA1 and BRCA2 Founder Mutations and the Risk of Colorectal Cancer
Limitations of the Gail Model in the Specialized Breast Cancer Risk Assessment Clinic
Preempting Genetic Discrimination and Assaults on Privacy: Report of a Symposium
Outcome of Preventive Surgery and Screening for Breast and Ovarian Cancer in BRCA Mutation Carriers
Tubal Ligation and Risk of Ovarian Cancer in Carriers of Brca1 or BRCA2 Mutations: A Case-Control Study
Bilateral Prophylactic Mastectomy Reduces Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group
Clinical Characteristics of Individuals With Germline Mutations in BRCA1 and BRCA2: Analysis of 10,000 Individuals
BRCA Mutations and Risk of Prostate Cancer in Ashkenazi Jews
Fallopian Tube and Primary Peritoneal Carcinomas Associated With BRCA Mutations
Breast-feeding and the risk of breast cancer in BRCA1 and BRCA2
Impact of Germline Brca1 Mutations and Overexpression of P53 on Prognosis and Response to Treatment Following Breast Carcinoma: 10-Year Follow-Up Data
Modification of BRCA1- and BRCA2: Associated Breast Cancer Risk by AIB1 Genotypeand Reproductive History
Psychosocial Predictors of BRCA Counseling and Testing Decisions among Urban African-American Women
Breast Cancer after Prophylactic Bilateral Mastectomy in Women with a BRCA1 or BRCA2 Mutation
Hormone Replacement Therapy and Life Expectancy After Prophylactic Oophorectomy in Women With Mutations: A Decision Analysis
Understanding Mathematical Models for Breast Cancer Risk Assessment and Counseling
BRCA1 and BRCA2 Germline Mutations in Lymphoma Patients
Cancer Risk Estimates for BRCA1 Mutation Carriers Identified in a Risk Evaluation Program
Breast Cancer Risk Assessment Models: Applicability to African-American women
Low-Penetrance Susceptibility to Breast Cancer Due to CHEK2*1100delC in Noncarriers of BRCA1 or BRCA2 Mutations
Cancer Genetics Network Ovarian Screening Study: Physician Practice Patterns in Screening Women at High Risk for Ovarian Cancer
Prophylactic Oophorectomy in Carriers of BRCA1 or BRCA2 Mutations
What Do Ratings of Cancer-Specific Distress Mean Among Women at High Risk of Breast and Ovarian Cancer?
Frequency of CHEK2*1100delC in New York Breast Cancer Cases and Controls
Long-Term Psychological Impact of Carrying a BRCA1/2 Mutation and Prophylactic Surgery: A 5-Year Follow-Up Study
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
Outcome of Conservatively Managed Early-Onset Breast Cancer by Brca1/2 Status
Improved Survival in Women with BRCA-Associated Ovarian Carcinoma
Outcome of five years of accelerated surveillance in patients at high risk for inherited breast/ovarian cancer
Survival In Prospectively Ascertained Familial Breast Cancer: Analysis of a Series Stratified By Tumour Characteristics, Brca Mutations and Oophorectomy
BRCA2 Mutation Carriers, Reproductive Factors and Breast Cancer Risk
Breast cancer genetics in African Americans
A Gonadotropin-Releasing Hormone Agonist (Gnrha)-Based Chemoprevention Regimen That Reduces Mammographic Density in Brca Carriers While Maintaining Good Quality of Life (Qol), Bone Density, and Reproductive Options
Risk-Reducing Salpingo-oophorectomy in Women with a BRCA1 or BRCA2 Mutation

Other breast cancer resources

Breast cancer information
Breast cancer symptoms
Information on breast cancer
Breast cancer Resources
Breast cancer Detailed account

Health Resources

Netwd Health Directory

Useful blogs

Science blog
Biology blog
Technology blog

Connections to other pages

Main page

Basics of women's health

Risk factors for breast cancer

Breast cancer statistics

Hormonal use and breast cancer

BRCA: Breast cancer genes

diagnosis-of-breast-cancer

Staging of breast cancer

Treatment of breast cancer

General resources

Cancer Journals

Breast cancer: Clinical trials

Stories of hope

Breast cancer support

End of life issues

Breast cancer books

Our book marks

Link groups